Navigation Links
Align Technology Announces Second Quarter Fiscal 2008 Results
Date:7/29/2008

- $211.2

Net Profit % 6% - 7% 1% 7% - 8%

Net Profit per Diluted

Share $0.26 - $0.30 $0.03 $0.29 - $0.33

Stock Based Compensation

Expense:

Cost of Revenues $1.7 $1.7

Operating Expenses $16.2 $16.2

Total Stock Based

Compensation Expense $17.9 $17.9

Increase in Deferred

Revenue $5.0 - $8.0 $5.0 - $8.0

Total Deferred Revenue

Balance $17.0 - $20.0 $17.0 - $20.0

(a) Restructuring charges

Business Metrics:

FY 2008

Case Shipments 213.0K - 216.5K

Cash $130M - $135M

DSO ~57 days

Capex $14.0M - $18.0M

Depreciation &

Amortization $13.0M - $14.0M

Diluted Shares

Outstanding 70.0M


'/>"/>
SOURCE Align Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Align Technology Executive to Present at Upcoming Financial Conferences
2. WellPoint Announces Realignment of Core Businesses; Names New Executives
3. Align Technology to Announce Third Quarter 2007 Financial Results on October 24, 2007
4. Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry
5. Test gives insight into prognosis in patients with plasma cell malignancies, finds Mayo Clinic study
6. Threshold Pharmaceuticals Announces Corporate Realignment
7. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
8. Dallas Among the First to Offer Probiotic Supplement Align(R)
9. McGill researchers link enzyme to breast cancer malignancy
10. Breast Cancer Genes Also Raise Mens Risk for Malignancy
11. iNOS expression may links chronic biliary inflammation to malignant transformation
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2Water conserving irrigation strategies minimize overwatering runoff 60696 1Water conserving irrigation strategies minimize overwatering runoff 60696 2Water conserving irrigation strategies minimize overwatering runoff 60696 3When should flu trigger a school shutdown 3F 60692 1When should flu trigger a school shutdown 3F 60692 2When should flu trigger a school shutdown 3F 60692 3Cholesterol and Cancer 3A Answers and Some New Questions 60688 1Cholesterol and Cancer 3A Answers and Some New Questions 60688 2Cholesterol and Cancer 3A Answers and Some New Questions 60688 3Cholesterol and Cancer 3A Answers and Some New Questions 60688 4Cholesterol and Cancer 3A Answers and Some New Questions 60688 5